BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $8,043,000 | -9.4% | 651,800 | 0.0% | 0.00% | -20.0% |
Q4 2016 | $8,878,000 | -35.0% | 651,800 | -5.1% | 0.01% | -28.6% |
Q3 2016 | $13,661,000 | +53.5% | 686,500 | 0.0% | 0.01% | +40.0% |
Q2 2016 | $8,897,000 | +38.6% | 686,500 | 0.0% | 0.01% | +66.7% |
Q1 2016 | $6,419,000 | -53.9% | 686,500 | 0.0% | 0.00% | -57.1% |
Q4 2015 | $13,915,000 | +34.2% | 686,500 | -3.8% | 0.01% | +40.0% |
Q3 2015 | $10,367,000 | -42.7% | 713,500 | -16.1% | 0.01% | -37.5% |
Q2 2015 | $18,086,000 | +25.9% | 850,300 | +37.1% | 0.01% | +14.3% |
Q1 2015 | $14,368,000 | +315.7% | 620,100 | +313.4% | 0.01% | +250.0% |
Q4 2014 | $3,456,000 | – | 150,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |